Zobrazeno 1 - 10
of 29
pro vyhledávání: '"m-RNA vaccine"'
Autor:
Neerja Saraswat, Durga M Tripathy, M Murali, Jahnabi Boruah, Debdeep Mitra, Harleen Chopra, Anuj Bhatnagar
Publikováno v:
Indian Dermatology Online Journal, Vol 14, Iss 6, Pp 814-820 (2023)
Background: Vigorous administration of COVID-19 vaccines to tackle the ongoing pandemic has led to increasing research on adverse effects including both systemic and cutaneous. Objective: A prospective observational study to delineate the cutaneous a
Externí odkaz:
https://doaj.org/article/dac988effc2248449fba57fc504b8c33
Publikováno v:
Pediatric Reports, Vol 14, Iss 4, Pp 401-409 (2022)
One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12–18. Since then, alarming reports of ca
Externí odkaz:
https://doaj.org/article/c9e316984f2d444f997b4bc0bb1f1b3a
Autor:
Sara Mohamed, Elisa Lucchini, Francesca Sirianni, Marika Porrazzo, Laura Ballotta, Mario Ballerini, Giovanni Maria De Sabbata, Eleonora De Bellis, Ilaria Cappuccio, Marilena Granzotto, Barbara Toffoletto, Ilaria Fortunati, Anna Russignan, Emilia Elzbieta Florea, Lucio Torelli, Francesco Zaja
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
messenger RNA (mRNA)-Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccines such as BNT162b2 became available in late 2020, but hematological malignancy patients (HM pts) were not evaluated in initial registration trials. We hereby repo
Externí odkaz:
https://doaj.org/article/4745d20e03614202b13ffcceaf23b8c2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vincenzo Restivo, Giuseppina Candore, Maria Barrale, Ester Caravello, Giorgio Graziano, Rosa Onida, Maurizio Raineri, Salvatore Tiralongo, Ignazio Brusca
Publikováno v:
Vaccines, Vol 9, Iss 5, p 412 (2021)
The main contraindication to the anti-SARS CoV2 vaccine is an anaphylactic reaction to a vaccine component. The need to vaccinate allergic people who are at higher risk can be of public health interest and this report shows a case of an allergic reac
Externí odkaz:
https://doaj.org/article/2d3c871974c043c8a471ae3cf735478b
Publikováno v:
Oral Diseases. 28:2624-2626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3beff22724e5fd8219e565d7b53987
https://doi.org/10.1111/odi.14184
https://doi.org/10.1111/odi.14184
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ignazio Brusca, Rosa Onida, Maurizio Raineri, Vincenzo Restivo, Maria Barrale, Salvatore Tiralongo, Ester Caravello, Giuseppina Candore, Giorgio Graziano
Publikováno v:
Vaccines, Vol 9, Iss 412, p 412 (2021)
Vaccines
Vaccines
The main contraindication to the anti-SARS CoV2 vaccine is an anaphylactic reaction to a vaccine component. The need to vaccinate allergic people who are at higher risk can be of public health interest and this report shows a case of an allergic reac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9ec4e1f9450f758cc837e7b45e4c72
https://www.mdpi.com/2076-393X/9/5/412
https://www.mdpi.com/2076-393X/9/5/412
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniela Borleri, Gavino Napolitano, Claudio Farina, Daniela Valenti, Marco Rizzi, Franco Maggiolo, Annapaola Callegaro
Publikováno v:
Journal of Medical Virology
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic calls for rapid actions, now principally oriented to a world‐wide vaccination campaign. In this study we verified if, in individuals with a previous SARS‐CoV‐2 infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb5cbeaa4f9c0155e6e2cd7fc442966
https://doi.org/10.1002/jmv.27263
https://doi.org/10.1002/jmv.27263